This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Containment Remove Drugs Remove Genetic Analysis Related Topics
Reagent In-Vivo Licensing Genetics Immune Response Gene Clinical Trials Gene Therapy FDA Approval Trials More Related Topics >
article thumbnail

Fighting viruses is as easy as breathing

The Pharma Data

APRIL 8, 2022

They also identified several drugs that reduced the production of inflammatory cytokines in infected Alveolus Chips, which could be useful in treating excessive inflammation in the lung. Based on these studies, one of those drugs was licensed to Cantex Pharmaceuticals for the treatment of COVID-19 and other inflammatory lung diseases.

Immune Response 52
Immune Response In-Vivo Genetic Analysis Research 52
article thumbnail

Blood Donor Day 2023: Experts weigh in 

Drug Discovery World

JUNE 14, 2023

In acknowledgement of Blood Donor Day 2023, DDW spoke with industry experts about the significance of blood donorship in drug discovery. Besides looking at donor characteristics, our platform, which we call Excellos 360TM, includes the assessment of metabolic and effector potential of cells, and genetic analysis.

Manufacturing 52
Manufacturing Production Gene Therapy Development 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024